Skip to main content
SpringerLink
Log in

Spasmolytika

  • Chapter
Arzneiverordnungs-Report 2007

  • 563 Accesses

Auszug

Die Verordnungen der Spasmolytika sind seit 1992 um 83% zurückgegangen. Die rückläufige Entwicklung hat sich 2006 weiter fortgesetzt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

Literatur

  • Duggan JM (1965): A controlled trial of an anticholinergic drug, pipenzolate methylbromide („piptal“), in the management of peptic ulcer. Med J Aust 2: 826–827.

    PubMed  CAS  Google Scholar 

  • Lesbros-Pantoflickova D, Michetti P, Fried M, Beglinger C, Blum AL (2004): Metaanalysis: The treatment of irritable bowel syndrome. Aliment Pharmacol Ther 20: 1253–1269.

    Article  PubMed  CAS  Google Scholar 

  • Poynard T, Regimbeau C, Benhamou Y (2001): Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 15: 355–361.

    Article  PubMed  CAS  Google Scholar 

  • Schäfer E, Ewe K (1990): Behandlung des Colon irritabile. Wirksamkeit und Verträglichkeit von Buscopan plus, Buscopan, Paracetamol und Plazebo bei ambulanten Patienten mit Colon irritabile. Fortschr Med 108: 488–492.

    PubMed  Google Scholar 

  • Schmieder G, Stankov G, Zerle G, Schinzel S, Brune K (1993): Observer-blind study with metamizole versus tramadol and butylscopolamine in acute biliary colic pain. Arzneim Forsch 43: 1216–1221.

    CAS  Google Scholar 

  • Tahir KI (1992): Return to Pakistan of pipenzolate plus phenobarbitone. Lancet 339: 498.

    Article  PubMed  CAS  Google Scholar 

  • Talley NJ (2003): Evaluation of drug treatment in irritable bowel syndrome. Br J Clin Pharmacol 56: 362–369.

    Article  PubMed  CAS  Google Scholar 

  • Vincent PC, Fenton BH, Beeston D (1967): The effect of pipenzolate on gastric secretion in man. Med J Aust 1: 546–548.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmakologisches Institut der Universität Heidelberg, Im Neuenheimer Feld 366, 69120, Heidelberg

    Prof. Dr. med. Ulrich Schwabe

Authors
  1. Prof. Dr. med. Ulrich Schwabe
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pharmakologisches Institut der Universität Heidelberg, Im Neuenheimer Feld 366, 69120, Heidelberg

    Ulrich Schwabe

  2. AOK Schleswig-Holstein Die Gesundheitskasse, Edisonstraße 70, 24145, Kiel

    Dieter Paffrath

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Schwabe, U. (2008). Spasmolytika. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs-Report 2007. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-72548-0_46

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-72548-0_46

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-72547-3

  • Online ISBN: 978-3-540-72548-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation